Drug Type Immunoglobulin |
Synonyms Dried sulfonated human immunoglobulin(KM Biologics/Teijin), KD 380, KD-380 + [3] |
Target |
Action inhibitors, stimulants |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors), Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (22 May 1979), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Optic Neuritis | Japan | 02 Dec 2019 | |
Optic Neuritis | Japan | 02 Dec 2019 | |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Japan | 02 Aug 2019 | |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Japan | 02 Aug 2019 | |
Churg-Strauss Syndrome | Japan | 01 Feb 2010 | |
Churg-Strauss Syndrome | Japan | 01 Feb 2010 | |
Infectious Diseases | Japan | 22 May 1979 | |
Infectious Diseases | Japan | 22 May 1979 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multifocal Motor Neuropathy | Phase 3 | Japan | - |